Skip to content

Effect of neogard protection to reduce nasal injury in preterm infants receiving N-CPAP

A comparative study on the effect of using nasal protector (Neo-Guard)on the incidence rate and severity of nasal injury in preterm infants treated with Nasal-Continuous Positive Airway Pressure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191217045769N1
Enrollment
80
Registered
2020-03-15
Start date
2019-12-31
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal injury associated with N-CPAP in preterm infants. Preterm [premature] newborn [other]

Interventions

Intervention 1: Intervention group will use neoguard nasal protector to prevent nasal injury. Intervention 2: Control group will receive routine care.

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 8 Months

Inclusion criteria

Inclusion criteria: Premature infants 32 weeks or less or premature infants weighing 1500 g or less who require N-CPAP Parents are satisfied with the baby's entry into the study.

Exclusion criteria

Exclusion criteria: Premature infants who are >32 weeks of postmenstrual age (PMA) or Premature infants(<37 weeks(PMA)) at a weight <1500 g The infant was intubated before receiving N-CPAP and received invasive ventilation Preterm infants who had facial features that might preclude treatment with binasal CPAP (eg, cleft lip, Pierre Robin sequence,choanal atresia)

Design outcomes

Primary

MeasureTime frame
Incidence and severity of nasal injury. Timepoint: Every 12 hours to 72 hours. Method of measurement: Check list.

Secondary

MeasureTime frame
N-CPAP failure or success rate. Timepoint: Time of removing neonatal from N-CPAP. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Jafari-Mianaei

Esfahan University of Medical Sciences

m_jafari@nm.mui.ac.ir+98 31 3792 7595

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026